Immucell Corp. (ICCC)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

56 EVERGREEN DR PORTLAND, ME 04103

Immucell Corp. operates as a biotechnology company that engages in the research and development, manufacture and sales of diagnostic tests and products for therapeutic and preventive use against certain infectious diseases in animals and humans.

Data as of 2020-05-30
Market Cap32.53 Million Shares Outstanding7.213 Million Avg 30-day Volume34.314 Thousand
P/E Ratio Dividend Yield EPS-0.22
Price/Sales2.287 Price cash flow ratio74.8 Price free cash flow ratio-15.2
Book Value4.02 Price to Tangible Book1.07 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.221207
BETA1.42919 52-week High/Low8.13 / 3.7 Stddev0.129902
View SEC Filings from ICCC instead.

View recent insider trading info

Funds Holding ICCC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ICCC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CUNNINGHAM DAVID

15,000 2020-03-12 1

TOMSCHE DAVID SCOTT

85,519 2020-03-11 2

RHODES LINDA

  • Director
0 2020-02-11 0

WILLIAMS ELIZABETH LUTTRELL VP OF MANUFACTURING OPERATIONS

0 2019-12-11 1

BROCKMANN BOBBI JO

3,779 2019-12-09 1

WAINMAN PAUL R

6,269 2019-03-11 0

PESSIN NORMAN H

  • SEE EXPLANATION OF RESPONSES
5,069,960 2019-02-01 0

BRIGHAM MICHAEL F PRESIDENT & CEO

204,752 2018-12-28 0

CRABB JOSEPH H VICE PRESIDENT AND CSO

141,845 2018-11-26 0

ROTHSCHILD JONATHAN E

0 2018-03-19 0

ROSGEN STEVEN T.

0 2018-03-19 0

PESSIN BRIAN L.

  • SEE EXPLANATION OF RESPONSES
70,000 2017-07-27 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments